| pigmentation | GO:0043473 | 71 | 0.989 | |
| amine metabolic process | GO:0009308 | 45 | 0.959 | |
| metanephric glomerulus vasculature morphogenesis | GO:0072276 | 3 | 0.934 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.928 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.928 | |
| cell fate commitment | GO:0045165 | 210 | 0.923 | |
| cation homeostasis | GO:0055080 | 212 | 0.887 | |
| protein localization to organelle | GO:0033365 | 185 | 0.878 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.854 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.854 | |
| response to macrophage colony stimulating factor | GO:0036005 | 3 | 0.842 | |
| stem cell proliferation | GO:0072089 | 117 | 0.842 | |
| mapk cascade | GO:0000165 | 281 | 0.833 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.829 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.828 | |
| maintenance of location | GO:0051235 | 89 | 0.813 | |
| tyrosine phosphorylation of stat1 protein | GO:0042508 | 3 | 0.812 | |
| leukocyte migration | GO:0050900 | 124 | 0.806 | |
| regionalization | GO:0003002 | 337 | 0.758 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.755 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.748 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.739 | |
| pigment cell differentiation | GO:0050931 | 27 | 0.736 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.736 | |
| positive regulation of long term neuronal synaptic plasticity | GO:0048170 | 3 | 0.734 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.724 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.723 | |
| asymmetric neuroblast division | GO:0055059 | 1 | 0.719 | |
| metanephric glomerular mesangium development | GO:0072223 | 3 | 0.709 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.696 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.694 | |
| mesenchyme development | GO:0060485 | 152 | 0.693 | |
| positive regulation of smooth muscle cell migration | GO:0014911 | 4 | 0.684 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.680 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.663 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.660 | |
| regulation of cell migration | GO:0030334 | 219 | 0.646 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.642 | |
| cell chemotaxis | GO:0060326 | 81 | 0.638 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.633 | |
| gliogenesis | GO:0042063 | 141 | 0.623 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.617 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.609 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.604 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.602 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.596 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.572 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.572 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.564 | |
| cell adhesion | GO:0007155 | 329 | 0.560 | |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.551 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.546 | |
| lipid homeostasis | GO:0055088 | 63 | 0.530 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.529 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.526 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.522 | |
| lung development | GO:0030324 | 164 | 0.521 | |
| heart morphogenesis | GO:0003007 | 178 | 0.520 | |
| regulation of tyrosine phosphorylation of stat1 protein | GO:0042510 | 2 | 0.515 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.513 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.511 | |
| limb development | GO:0060173 | 166 | 0.511 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.511 | |
| smooth muscle cell migration | GO:0014909 | 10 | 0.506 | |
| smooth muscle tissue development | GO:0048745 | 22 | 0.503 | |
| dendritic cell cytokine production | GO:0002371 | 3 | 0.499 | |
| negative regulation of anoikis | GO:2000811 | 2 | 0.496 | |
| cellular response to erythropoietin | GO:0036018 | 1 | 0.496 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.495 | |
| melanocyte migration | GO:0097324 | 2 | 0.494 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.491 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.479 | |
| placenta development | GO:0001890 | 140 | 0.474 | |
| regulation of hippo signaling | GO:0035330 | 1 | 0.473 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.465 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.462 | |
| platelet derived growth factor receptor beta signaling pathway | GO:0035791 | 4 | 0.457 | |
| embryonic placenta development | GO:0001892 | 98 | 0.454 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.450 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.448 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.446 | |
| myeloid leukocyte migration | GO:0097529 | 57 | 0.444 | |
| cell cell signaling involved in cell fate commitment | GO:0045168 | 35 | 0.444 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.443 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.441 | |
| stem cell development | GO:0048864 | 219 | 0.440 | |
| negative regulation of dna replication | GO:0008156 | 4 | 0.439 | |
| cellular homeostasis | GO:0019725 | 240 | 0.436 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.435 | |
| cell division | GO:0051301 | 120 | 0.427 | |
| platelet derived growth factor receptor alpha signaling pathway | GO:0035790 | 3 | 0.424 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.414 | |
| cell migration involved in coronary angiogenesis | GO:0060981 | 1 | 0.413 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.411 | |
| spermatogenesis | GO:0007283 | 284 | 0.410 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.409 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.407 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.405 | |
| cation transport | GO:0006812 | 399 | 0.401 | |
| muscle system process | GO:0003012 | 141 | 0.400 | |
| neuroepithelial cell differentiation | GO:0060563 | 37 | 0.400 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.399 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.396 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.396 | |
| negative regulation of glial cell proliferation | GO:0060253 | 4 | 0.396 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.396 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.395 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.393 | |
| single organism nuclear import | GO:1902593 | 95 | 0.390 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.382 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.379 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.372 | |
| synaptic transmission | GO:0007268 | 329 | 0.370 | |
| cell migration involved in vasculogenesis | GO:0035441 | 2 | 0.369 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.365 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.364 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.362 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.358 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.356 | |
| cellular response to radiation | GO:0071478 | 28 | 0.353 | |
| kit signaling pathway | GO:0038109 | 3 | 0.350 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.348 | |
| regulation of smooth muscle cell migration | GO:0014910 | 6 | 0.347 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.347 | |
| positive regulation of chemotaxis | GO:0050921 | 38 | 0.347 | |
| regulation of developmental pigmentation | GO:0048070 | 14 | 0.346 | |
| regulation of protein localization | GO:0032880 | 231 | 0.343 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.343 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.339 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.337 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.337 | |
| positive regulation of cell proliferation involved in heart valve morphogenesis | GO:0003251 | 1 | 0.335 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.335 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.330 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.330 | |
| erythropoietin mediated signaling pathway | GO:0038162 | 1 | 0.328 | |
| male gamete generation | GO:0048232 | 285 | 0.327 | |
| t cell activation | GO:0042110 | 289 | 0.325 | |
| dendrite development | GO:0016358 | 115 | 0.325 | |
| positive regulation of tyrosine phosphorylation of stat1 protein | GO:0042511 | 1 | 0.324 | |
| somite specification | GO:0001757 | 4 | 0.323 | |
| keratinocyte proliferation | GO:0043616 | 21 | 0.322 | |
| gland development | GO:0048732 | 330 | 0.322 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.320 | |
| immune effector process | GO:0002252 | 321 | 0.320 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.319 | |
| neuroblast proliferation | GO:0007405 | 49 | 0.318 | |
| chemotaxis | GO:0006935 | 247 | 0.316 | |
| regulation of protein stability | GO:0031647 | 52 | 0.315 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.315 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.314 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.313 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.313 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.313 | |
| epithelial cell migration | GO:0010631 | 63 | 0.312 | |
| lipid localization | GO:0010876 | 126 | 0.311 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.306 | |
| membrane organization | GO:0061024 | 245 | 0.306 | |
| dna metabolic process | GO:0006259 | 303 | 0.303 | Human |
| regulation of pseudopodium assembly | GO:0031272 | 1 | 0.302 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.302 | |
| nephron development | GO:0072006 | 109 | 0.299 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.299 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 58 | 0.298 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.297 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.296 | |
| digestive tract development | GO:0048565 | 190 | 0.295 | |
| developmental maturation | GO:0021700 | 193 | 0.292 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.291 | |
| protein targeting | GO:0006605 | 143 | 0.285 | |
| tyrosine phosphorylation of stat5 protein | GO:0042506 | 9 | 0.285 | |
| digestive system development | GO:0055123 | 200 | 0.281 | |
| metanephric glomerular mesangial cell proliferation involved in metanephros development | GO:0072262 | 3 | 0.279 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.279 | |
| endothelial cell differentiation | GO:0045446 | 41 | 0.278 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.277 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.277 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.277 | |
| regulation of cell motility | GO:2000145 | 236 | 0.274 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.274 | |
| canonical wnt signaling pathway involved in negative regulation of apoptotic process | GO:0044336 | 4 | 0.271 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.268 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.267 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.266 | |
| leukocyte degranulation | GO:0043299 | 27 | 0.266 | |
| positive regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway | GO:0035793 | 1 | 0.259 | |
| melanocyte differentiation | GO:0030318 | 25 | 0.258 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.258 | |
| salivary gland morphogenesis | GO:0007435 | 33 | 0.257 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.256 | |
| response to erythropoietin | GO:0036017 | 1 | 0.255 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.255 | |
| lymphocyte homeostasis | GO:0002260 | 64 | 0.254 | |
| intracellular protein transport | GO:0006886 | 204 | 0.253 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.251 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.251 | |
| mesenchymal cell proliferation | GO:0010463 | 44 | 0.249 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.247 | |
| notch signaling pathway | GO:0007219 | 71 | 0.247 | |
| response to nutrient levels | GO:0031667 | 109 | 0.247 | |
| cell migration involved in metanephros development | GO:0035788 | 2 | 0.246 | |
| negative regulation of cyclin dependent protein serine threonine kinase activity | GO:0045736 | 9 | 0.245 | |
| respiratory tube development | GO:0030323 | 167 | 0.245 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.244 | |
| negative regulation of transcription involved in g1 s transition of mitotic cell cycle | GO:0071930 | 1 | 0.242 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.242 | |
| nuclear import | GO:0051170 | 95 | 0.241 | |
| nuclear transport | GO:0051169 | 139 | 0.240 | |
| negative regulation of photoreceptor cell differentiation | GO:0046533 | 4 | 0.239 | |
| angiogenesis | GO:0001525 | 201 | 0.238 | |
| stem cell maintenance | GO:0019827 | 130 | 0.237 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.236 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.235 | |
| cellular response to lipid | GO:0071396 | 145 | 0.234 | |
| ectopic germ cell programmed cell death | GO:0035234 | 9 | 0.230 | |
| lamellipodium organization | GO:0097581 | 29 | 0.229 | |
| regulation of renal sodium excretion | GO:0035813 | 3 | 0.227 | |
| cardiac endothelial cell differentiation | GO:0003348 | 4 | 0.225 | |
| stem cell differentiation | GO:0048863 | 268 | 0.225 | |
| lateral inhibition | GO:0046331 | 1 | 0.223 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.222 | |
| regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway | GO:1900238 | 1 | 0.222 | |
| glial cell differentiation | GO:0010001 | 131 | 0.221 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.220 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.220 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.220 | |
| regulation of camp metabolic process | GO:0030814 | 30 | 0.219 | |
| gastrulation | GO:0007369 | 116 | 0.218 | |
| hindbrain development | GO:0030902 | 128 | 0.218 | |
| transmembrane transport | GO:0055085 | 412 | 0.218 | |
| regulation of protein import into nucleus | GO:0042306 | 52 | 0.217 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.216 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.215 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.213 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.213 | |
| mesoderm development | GO:0007498 | 100 | 0.211 | |
| urogenital system development | GO:0001655 | 261 | 0.210 | |
| limb morphogenesis | GO:0035108 | 149 | 0.210 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.209 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.209 | |
| sprouting angiogenesis | GO:0002040 | 26 | 0.207 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 47 | 0.207 | |
| response to host defenses | GO:0052200 | 3 | 0.206 | |
| positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | GO:1902043 | 13 | 0.206 | |
| osteoclast differentiation | GO:0030316 | 62 | 0.205 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.205 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.203 | |
| regulation of glial cell differentiation | GO:0045685 | 41 | 0.203 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.201 | |
| neural crest cell migration | GO:0001755 | 32 | 0.200 | |
| pigment metabolic process | GO:0042440 | 32 | 0.200 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.199 | |
| renal system vasculature morphogenesis | GO:0061438 | 7 | 0.199 | |
| adherens junction organization | GO:0034332 | 28 | 0.199 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.199 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.198 | |
| microtubule based process | GO:0007017 | 236 | 0.198 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.197 | |
| myeloid leukocyte cytokine production | GO:0061082 | 12 | 0.196 | |
| regulation of gliogenesis | GO:0014013 | 50 | 0.196 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.194 | |
| extrinsic apoptotic signaling pathway via death domain receptors | GO:0008625 | 34 | 0.194 | |
| regulation of catenin import into nucleus | GO:0035412 | 5 | 0.193 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.193 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.193 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.192 | |
| striated muscle cell development | GO:0055002 | 125 | 0.192 | |
| ovulation cycle | GO:0042698 | 59 | 0.191 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.190 | |
| circulatory system process | GO:0003013 | 197 | 0.190 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.189 | |
| regulation of vasculogenesis | GO:2001212 | 9 | 0.189 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.188 | |
| artery development | GO:0060840 | 53 | 0.188 | |
| negative regulation of smoothened signaling pathway | GO:0045879 | 25 | 0.186 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.186 | |
| regulation of smad protein import into nucleus | GO:0060390 | 3 | 0.186 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 39 | 0.186 | |
| cellular response to epidermal growth factor stimulus | GO:0071364 | 4 | 0.185 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.185 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.184 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.183 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.183 | |
| formation of radial glial scaffolds | GO:0021943 | 4 | 0.183 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.183 | |
| muscle contraction | GO:0006936 | 101 | 0.182 | |
| response to defenses of other organism involved in symbiotic interaction | GO:0052173 | 3 | 0.182 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.180 | |
| megakaryocyte differentiation | GO:0030219 | 26 | 0.180 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.180 | |
| axonogenesis | GO:0007409 | 274 | 0.179 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.178 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.178 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.178 | |
| renal system development | GO:0072001 | 225 | 0.178 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.178 | |
| positive regulation of ion transmembrane transport | GO:0034767 | 24 | 0.177 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.177 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.175 | |
| cartilage development | GO:0051216 | 140 | 0.175 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.174 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.173 | |
| positive regulation of glial cell proliferation | GO:0060252 | 4 | 0.173 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.173 | |
| metanephric glomerulus morphogenesis | GO:0072275 | 3 | 0.172 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.172 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.172 | |
| regulation of cell activation | GO:0050865 | 289 | 0.172 | |
| positive regulation of dna biosynthetic process | GO:2000573 | 4 | 0.171 | |
| regulation of nucleotide biosynthetic process | GO:0030808 | 34 | 0.170 | |
| ossification | GO:0001503 | 216 | 0.170 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.169 | |
| neuronal action potential | GO:0019228 | 54 | 0.169 | |
| tolerance induction to self antigen | GO:0002513 | 4 | 0.168 | |
| negative regulation of b cell differentiation | GO:0045578 | 4 | 0.167 | |
| pallium development | GO:0021543 | 120 | 0.167 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.166 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.165 | |
| cellular response to thyroid hormone stimulus | GO:0097067 | 1 | 0.165 | |
| appendage development | GO:0048736 | 166 | 0.163 | |
| cell junction organization | GO:0034330 | 77 | 0.162 | |
| hair cycle | GO:0042633 | 90 | 0.162 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.160 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.159 | |
| positive regulation of tor signaling | GO:0032008 | 3 | 0.159 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.159 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.159 | |
| neuron projection guidance | GO:0097485 | 141 | 0.158 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.158 | |
| photoreceptor cell morphogenesis | GO:0008594 | 3 | 0.158 | |
| negative regulation of cell fate specification | GO:0009996 | 4 | 0.157 | |
| muscle tissue development | GO:0060537 | 308 | 0.156 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.156 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.156 | |
| regulation of tyrosine phosphorylation of stat5 protein | GO:0042522 | 8 | 0.156 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.155 | |
| protein catabolic process | GO:0030163 | 221 | 0.154 | |
| regulation of mesenchymal cell proliferation | GO:0010464 | 37 | 0.153 | |
| response to thyroid hormone | GO:0097066 | 2 | 0.153 | |
| pseudopodium organization | GO:0031268 | 2 | 0.153 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.153 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.152 | |
| pancreas development | GO:0031016 | 57 | 0.152 | |
| sensory perception | GO:0007600 | 245 | 0.152 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.152 | |
| regulation of transcription involved in g1 s transition of mitotic cell cycle | GO:0000083 | 3 | 0.152 | |
| defense response to other organism | GO:0098542 | 197 | 0.152 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.151 | |
| ovarian follicle development | GO:0001541 | 40 | 0.151 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.151 | |
| dna damage response signal transduction by p53 class mediator | GO:0030330 | 19 | 0.150 | |
| spermatid differentiation | GO:0048515 | 115 | 0.150 | |
| connective tissue development | GO:0061448 | 179 | 0.149 | |
| positive regulation of bmp signaling pathway | GO:0030513 | 23 | 0.149 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.149 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.149 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.148 | |
| response to ionizing radiation | GO:0010212 | 42 | 0.148 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.148 | |
| response to oxidative stress | GO:0006979 | 123 | 0.147 | |
| metanephric glomerular capillary formation | GO:0072277 | 3 | 0.147 | |
| germ cell development | GO:0007281 | 185 | 0.147 | |
| regulation of cardiac cell fate specification | GO:2000043 | 1 | 0.147 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.146 | |
| muscle cell migration | GO:0014812 | 19 | 0.146 | |
| response to light stimulus | GO:0009416 | 135 | 0.145 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.144 | |
| regulation of metanephric mesenchymal cell migration | GO:2000589 | 2 | 0.143 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.142 | |
| response to host | GO:0075136 | 3 | 0.142 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.142 | |
| detection of mechanical stimulus involved in equilibrioception | GO:0050973 | 2 | 0.141 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.141 | |
| tissue homeostasis | GO:0001894 | 115 | 0.141 | |
| immature b cell differentiation | GO:0002327 | 10 | 0.139 | |
| regulation of cyclic nucleotide metabolic process | GO:0030799 | 40 | 0.139 | |
| dna endoreduplication | GO:0042023 | 4 | 0.139 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.138 | |
| anoikis | GO:0043276 | 6 | 0.138 | |
| oligodendrocyte differentiation | GO:0048709 | 53 | 0.138 | |
| negative regulation of response to oxidative stress | GO:1902883 | 10 | 0.138 | |
| sensory perception of sound | GO:0007605 | 97 | 0.137 | |
| renal sodium excretion | GO:0035812 | 3 | 0.137 | |
| cgmp mediated signaling | GO:0019934 | 3 | 0.136 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.135 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.134 | |
| vasodilation | GO:0042311 | 28 | 0.134 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.134 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.133 | |
| metanephric mesenchymal cell migration | GO:0035789 | 2 | 0.131 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.131 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.131 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.130 | |
| regulation of tight junction assembly | GO:2000810 | 2 | 0.130 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.130 | |
| skeletal system development | GO:0001501 | 356 | 0.129 | |
| gtp catabolic process | GO:0006184 | 143 | 0.129 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.129 | |
| positive regulation of skeletal muscle tissue regeneration | GO:0043415 | 4 | 0.129 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.129 | Human |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.128 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.128 | |
| cell maturation | GO:0048469 | 127 | 0.127 | |
| cellular response to macrophage colony stimulating factor stimulus | GO:0036006 | 3 | 0.127 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.127 | |
| blood circulation | GO:0008015 | 195 | 0.126 | |
| midgut development | GO:0007494 | 4 | 0.125 | |
| oocyte axis specification | GO:0007309 | 2 | 0.124 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.124 | |
| positive regulation of mesenchymal cell proliferation | GO:0002053 | 33 | 0.124 | |
| epithelium migration | GO:0090132 | 63 | 0.124 | |
| salivary gland development | GO:0007431 | 37 | 0.124 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.123 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.123 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.122 | |
| regulation of erythrocyte differentiation | GO:0045646 | 23 | 0.121 | |
| regulation of ph | GO:0006885 | 26 | 0.121 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.121 | |
| neuron maturation | GO:0042551 | 29 | 0.120 | |
| kidney development | GO:0001822 | 213 | 0.120 | |
| extracellular structure organization | GO:0043062 | 148 | 0.120 | |
| vascular endothelial growth factor receptor signaling pathway | GO:0048010 | 24 | 0.119 | |
| endothelial cell migration | GO:0043542 | 44 | 0.119 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.118 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.118 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.118 | |
| organelle assembly | GO:0070925 | 177 | 0.118 | |
| regulation of b cell differentiation | GO:0045577 | 23 | 0.118 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.118 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.118 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.118 | |
| negative regulation of leukocyte differentiation | GO:1902106 | 51 | 0.117 | |
| multicellular organism growth | GO:0035264 | 161 | 0.117 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.116 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.116 | |
| protein import | GO:0017038 | 101 | 0.115 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.115 | |
| regulation of cyclin dependent protein serine threonine kinase activity | GO:0000079 | 16 | 0.114 | |
| spermatid development | GO:0007286 | 108 | 0.114 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.113 | |
| positive regulation of ion transport | GO:0043270 | 65 | 0.113 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.113 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.112 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.112 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.112 | |
| muscle cell development | GO:0055001 | 133 | 0.112 | |
| response to stem cell factor | GO:0036215 | 3 | 0.112 | |
| tor signaling | GO:0031929 | 21 | 0.112 | |
| skin development | GO:0043588 | 220 | 0.111 | |
| cartilage condensation | GO:0001502 | 18 | 0.111 | |
| regulation of anoikis | GO:2000209 | 2 | 0.109 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.109 | |
| neutrophil migration | GO:1990266 | 37 | 0.109 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.109 | |
| autophagy | GO:0006914 | 45 | 0.109 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.109 | |
| ureteric bud development | GO:0001657 | 94 | 0.109 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.108 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.108 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.108 | |
| mesenchyme morphogenesis | GO:0072132 | 32 | 0.108 | |
| pro t cell differentiation | GO:0002572 | 3 | 0.108 | |
| actin filament based movement | GO:0030048 | 23 | 0.108 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.107 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.106 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.106 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.106 | |
| visual behavior | GO:0007632 | 45 | 0.106 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.106 | |
| cell cycle switching | GO:0060184 | 1 | 0.105 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.105 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.105 | |
| organelle localization | GO:0051640 | 179 | 0.105 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.105 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.104 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.104 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.104 | |
| regulation of muscle contraction | GO:0006937 | 49 | 0.104 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.103 | |
| positive regulation of myeloid cell differentiation | GO:0045639 | 43 | 0.103 | |
| cardiac myofibril assembly | GO:0055003 | 12 | 0.102 | |
